Quibim

Quibim develops a cloud-based, tissue-agnostic platform designed to extract radiomics and deep features from medical imaging data. The company provides software as a medical device (SaMD) for healthcare providers to assist in the diagnosis and monitoring of conditions related to the prostate, brain, liver, breast, and lungs. Additionally, it partners with biopharma companies to accelerate drug development programs by identifying clinical study candidates and monitoring treatment toxicity through AI models.